SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000935836-20-000676
Filing Date
2020-12-03
Accepted
2020-12-03 16:06:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 olma13d.htm SC 13D 80501
  Complete submission text file 0000935836-20-000676.txt   82007
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91849 | Film No.: 201366980
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

IRS No.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D